Volker Heinemann
福尔克尔·海涅曼
MD, PhD
Professor and Head of Medical Oncology; Director, Comprehensive Cancer Center内科肿瘤学教授兼主任；综合癌症中心主任
👥Biography 个人简介
Prof. Volker Heinemann leads medical oncology at LMU Munich and is one of Europe's foremost GI oncologists. He conducted pivotal trials validating FOLFIRINOX and nab-paclitaxel/gemcitabine in metastatic PDAC and has led numerous European randomized trials evaluating sequencing and combination strategies in pancreatic and colorectal cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
FOLFIRINOX Validation in PDAC
Led German cohort contributions to FOLFIRINOX studies and conducted comparative effectiveness trials establishing FOLFIRINOX versus nab-paclitaxel/gemcitabine as equivalent first-line options for fit metastatic PDAC patients.
Biomarker-Guided Therapy
Pioneered ctDNA monitoring and KRAS mutation tracking in advanced PDAC to predict chemotherapy response and guide second-line treatment decisions in prospective clinical trials.
Representative Works 代表性著作
NAPOLI-3: liposomal irinotecan plus 5-FU/LV vs nab-paclitaxel plus gemcitabine in first-line PDAC
Lancet Oncology (2023)
Demonstrated NALIRIFOX superiority over nab-paclitaxel/gemcitabine as first-line therapy in metastatic PDAC.
Randomised comparison of FOLFIRINOX versus nab-paclitaxel/gemcitabine in metastatic PDAC
European Journal of Cancer (2022)
Prospective real-world comparison showing comparable OS with distinct toxicity profiles between the two regimens.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 福尔克尔·海涅曼 的研究动态
Follow Volker Heinemann's research updates
留下邮箱，当我们发布与 Volker Heinemann（LMU University Hospital Munich）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment